ConductScience.org, home

Trial · NCT06530290

Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients

NCT06530290, Phase 2, Unknown, Leila Dargahi. PharmD PhD

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients. Trials, record NCT06530290. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06530290

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients
NCT number
NCT06530290
Status
Unknown
Phases
Phase 2
Enrollment
64 participants, estimated
Lead sponsor
Leila Dargahi. PharmD PhD
Conditions
Parkinson Disease, Anxiety
Interventions
Mirtazapine 15 MG, Placebo
First posted
2024-07-31
Last updated
2025-05-21

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAnxiety scoreBaseline, and after 4 and 12 weeks of treatmentAnxiety score using Hamilton Anxiety Rating Scale (HAM-A)
PrimaryAnxiety scoreBaseline, and after 4 and 12 weeks of treatmentParkinson Anxiety Scale (PAS) questionnaires
SecondaryDepression scoreBaseline, and after 4 and 12 weeks of treatmentDepression score using Hamilton Depression Rating Scale (HAM-D) questionnaire
SecondaryFatigue scoreBaseline, and after 4 and 12 weeks of treatmentFatigue score using Parkinson's Disease Fatigue Scale (PDFS) questionnaire
SecondarySleep disorder scoreBaseline, and after 4 and 12 weeks of treatmentSleep disorder score using Parkinson's disease Sleep Scale (PDSS) questionnaire
SecondaryQuality of life scoreBaseline, and after 4 and 12 weeks of treatmentQuality of life score using Parkinson's Disease Quality of Life (PDQL) questionnaire

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06530290

GET https://conductscience.org/api/trials/v1/NCT06530290/registered